| First Author | Sinnamon JR | Year | 2020 |
| Journal | Cell Rep | Volume | 32 |
| Issue | 2 | Pages | 107878 |
| PubMed ID | 32668243 | Mgi Jnum | J:300850 |
| Mgi Id | MGI:6489102 | Doi | 10.1016/j.celrep.2020.107878 |
| Citation | Sinnamon JR, et al. (2020) In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing. Cell Rep 32(2):107878 |
| abstractText | Programmable RNA editing is gaining momentum as an approach to repair mutations, but its efficiency in repairing endogenous mutant RNA in complex tissue is unknown. Here we apply this approach to the brain and successfully repair a guanosine-to-adenosine mutation in methyl CpG binding protein 2 RNA that causes the neurodevelopmental disease Rett syndrome. Repair is mediated by hippocampal injections of juvenile Mecp2(317G>A) mice with an adeno-associated virus expressing the hyperactive catalytic domain of adenosine deaminase acting on RNA 2 and Mecp2 guide. After 1 month, 50% of Mecp2 RNA is recoded in three different hippocampal neuronal populations. MeCP2 protein localization to heterochromatin is restored in neurons to 50% of wild-type levels. Whole-transcriptome RNA analysis of one neuronal population indicates that the majority of off-target editing sites exhibit rates of 30% or less. This study demonstrates that programmable RNA editing can be utilized to repair mutations in mouse models of neurological disease. |
